Mr. Marc Lemieux reports

KDA GROUP ANNOUNCES CLOSING OF PRIVATE PLACEMENT

KDA Group Inc. has closed a private placement with accredited investors totalling 8.8 million units at a price of 25 cents per unit for total gross proceeds of $2.2-million.

Each unit consists of one Class A share of KDA and one common share purchase warrant. Each warrant entitles the holder to purchase one additional common share of the corporation at an exercise price of 35 cents per common share for a period of 24 months ending May 29, 2027.

All securities issued pursuant to the private placement are subject to a mandatory four-month-and-one-day hold period expiring on Sept. 30, 2025, in accordance with applicable securities regulations.

KDA will use the private placement proceeds for its working capital and general corporate purposes. No finder's fee nor commission are payable in connection with the private placement.

The private placement was carried out pursuant to prospectus exemptions of applicable securities laws and is subject to final acceptance by the TSX Venture Exchange.

Marc Lemieux, an officer and director of the corporation, purchased 80,000 units for a total consideration of $20,000. Mr. Lemieux is hereinafter referred to as the "insider."

The insider is considered "related party" and insider of the corporation for the purposes of applicable securities laws and stock exchange rules. The subscription and issuance of units by the insider constitutes a related party transaction but is exempt from the formal valuation and minority approval requirements of Regulation 61-101 respecting Protection of Minority Security Holders in Special Transactions as neither the fair market value of the common shares and warrants issued to the insider, nor the consideration paid by such insider, exceeds 25 per cent of the corporation's market capitalization.

About KDA Group Inc.

KDA Group is a leader in technological innovations and specialized software solutions (SaaS -- software-as-a-service) for the health care professionals' market. KDA is a corporation that offers quality products and has respected expertise among the various stakeholders in the pharmaceutical and medical sectors. The technology products developed by KDA aim, among other things, to accelerate the health care's digital transformation, and are available for the Canadian and international markets.

We seek Safe Harbor.